Conmed Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 02:00PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to host our next session, which is with CONMED. I have Curt Hartman, the CEO and joining us afterwards for Q&A will be Todd Garner, the CFO.

Just some housekeeping, feel free to submit questions online or e-mail or chat on Bloomberg. I'll do my best to answer all of them during the session.

So with that, Curt, I'll turn it over to you and join you in a little bit.

Curt R. Hartman - CONMED Corporation - Chairman of the Board, CEO & President

Thank you, Robbie, and good morning, everybody. Thank you for joining Tom this morning here at the 40th Annual JPMorgan Conference in a virtual format. There's a presentation that all of you should have access to, and I'll be calling out page numbers as I move forward here. On Page 2, you'll see our forward-looking information statement. Really no changes in that but in there for your consideration.

Going to Page 3, it's titled

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot